secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K/A
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0000950170-23-048877
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical amends Investor Day slide: 2026E Adj. EBITDA ex. SBC range raised to $90M-$120M
--------------------------------------------------------------------------------

- Adjusted EBITDA ex. SBC for 2026E corrected to $90M-$120M from previously stated $75M-$110M.
- CapEx expected ~$20-$30M annually; 2026E free cash flow estimated at $75-$110M.
- Clarification relates solely to slide 108 of the September 14, 2023 Investor Day presentation.
- No other projections or statements from the original 8-K were amended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017023048877/0000950170-23-048877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017023048877/staa-20230914.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-048877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer